Candel Therapeutics formalizes CFO employment agreement with $468,600 salary, 40% target bonus

Candel Therapeutics, Inc.

CFO Charles Schoch's new agreement sets base salary at $468,600 and target annual bonus at 40% of base.
Severance on termination without cause or for good reason: 9 months base salary plus target bonus.
Time-based equity awards fully accelerate if termination occurs within 1 month before or 12 months after change in control.
Agreement includes standard confidentiality, non-compete, and non-solicitation covenants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.